Loading... Please wait...

Inozyme Pharma, Inc. (INZY) Ownership

Currency in USD Disclaimer
$4.49 -$0 (0%)
$4.42
$4.5
$2.69
$7.8
  • RECENT QUARTER TOTAL INVESTED

    $382.04 M

      $168.87 M

  • RECENT QUARTER INSTITUTIONAL OWNERSHIP PERCENTAGE

    96.21%

      8.05%

  • TOTAL INVESTED OF LAST QUARTER

    $213.17 M
  • OWNERSHIP PERCENTAGE OF LAST QUARTER

    88.16%
*Showing results of the last quarter update as of 03/31/2024

Inozyme Pharma, Inc. Major Shareholders & Ownership History


Reporting Date Major Shareholder Name Shares Held Market Value Change in Shares Ownership
05/15/2024 ADAGE CAPITAL PARTNERS GP, L.L.C. 5.33 M $40.82 M   -3.77% 10.28%
05/14/2024 PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC 4.49 M $34.43 M   0.00% 8.67%
05/15/2024 SOFINNOVA INVESTMENTS, INC. 4.28 M $32.79 M   0.00% 8.26%
05/15/2024 ROCK SPRINGS CAPITAL MANAGEMENT LP 3.68 M $28.20 M   0.00% 7.10%
05/15/2024 EVENTIDE ASSET MANAGEMENT, LLC 3.18 M $24.36 M   0.00% 6.13%
05/10/2024 BLACKROCK INC. 3.09 M $23.66 M   1.52% 5.96%
05/15/2024 SAMLYN CAPITAL, LLC 2.91 M $22.31 M   -13.63% 5.62%
05/14/2024 AFFINITY ASSET ADVISORS, LLC 2.64 M $20.24 M   40.13% 5.10%
05/15/2024 NEA MANAGEMENT COMPANY, LLC 2.44 M $18.67 M   0.00% 4.70%
05/10/2024 VANGUARD GROUP INC 2.42 M $18.53 M   1.43% 4.67%
05/13/2024 FMR LLC 1.97 M $15.07 M   -13.42% 3.80%
05/15/2024 SAMSARA BIOCAPITAL, LLC 1.56 M $11.97 M   0.00% 3.01%
05/15/2024 SPHERA FUNDS MANAGEMENT LTD. 1.37 M $10.52 M   -12.16% 2.65%
05/15/2024 BLUE OWL CAPITAL HOLDINGS LP 1.27 M $9.73 M   0.00% 2.45%
05/13/2024 GEODE CAPITAL MANAGEMENT, LLC 1.07 M $8.18 M   3.37% 2.06%
05/15/2024 WOODLINE PARTNERS LP 888,067 $6.80 M   196.02% 1.71%
05/15/2024 STATE STREET CORP 880,639 $6.75 M   17.96% 1.70%
05/15/2024 MILLENNIUM MANAGEMENT LLC 703,606 $5.39 M   -22.80% 1.36%
05/14/2024 KNOTT DAVID M JR 564,549 $4.32 M   0.00% 1.09%
05/15/2024 KENNEDY CAPITAL MANAGEMENT LLC 437,657 $3.35 M   52.21% 0.84%
05/14/2024 NORTHERN TRUST CORP 419,879 $3.22 M   -1.14% 0.81%
05/15/2024 GOLDMAN SACHS GROUP INC 409,923 $3.14 M   12.81% 0.79%
05/15/2024 LAURION CAPITAL MANAGEMENT LP 402,197 $3.08 M   -27.83% 0.78%
05/15/2024 EXOME ASSET MANAGEMENT LLC 273,413 $2.09 M   100.00% 0.53%
05/15/2024 WELLINGTON MANAGEMENT GROUP LLP 244,200 $1.87 M   100.00% 0.47%
05/15/2024 PARKMAN HEALTHCARE PARTNERS LLC 222,943 $1.71 M   4.95% 0.43%
04/16/2024 OVERBROOK MANAGEMENT CORP 219,326 $1.68 M   0.00% 0.42%
05/15/2024 UBS OCONNOR LLC 183,218 $1.40 M   -25.20% 0.35%
05/10/2024 DIMENSIONAL FUND ADVISORS LP 174,647 $1.34 M   174.24% 0.34%
05/13/2024 RENAISSANCE TECHNOLOGIES LLC 173,700 $1.33 M   -20.50% 0.34%
04/25/2024 BANK OF NEW YORK MELLON CORP 164,432 $1.26 M   4.06% 0.32%
05/13/2024 NUVEEN ASSET MANAGEMENT, LLC 160,879 $1.23 M   0.00% 0.31%
05/03/2024 GSA CAPITAL PARTNERS LLP 131,098 $1.00 M   -21.50% 0.25%
05/09/2024 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 126,535 $969,258   4.02% 0.24%
05/15/2024 MORGAN STANLEY 124,246 $951,724   7.59% 0.24%
05/15/2024 SUPERSTRING CAPITAL MANAGEMENT LP 112,739 $863,581   -9.04% 0.22%
05/15/2024 CITADEL ADVISORS LLC 92,718 $710,220   -41.86% 0.18%
05/15/2024 SCHONFELD STRATEGIC ADVISORS LLC 74,800 $572,968   -31.19% 0.14%
05/09/2024 RHUMBLINE ADVISERS 63,137 $483,619   4.72% 0.12%
05/15/2024 PRELUDE CAPITAL MANAGEMENT, LLC 62,445 $478,329   100.00% 0.12%
05/10/2024 JPMORGAN CHASE & CO 61,577 $471,680   79.34% 0.12%
05/15/2024 BANK OF AMERICA CORP /DE/ 59,894 $458,788   -18.73% 0.12%
05/14/2024 AMERICAN CENTURY COMPANIES INC 51,427 $393,931   79.22% 0.10%
05/13/2024 UBS GROUP AG 47,960 $367,374   3.79% 0.09%
05/14/2024 ALPS ADVISORS INC 43,560 $333,670   3.19% 0.08%
05/15/2024 TWO SIGMA ADVISERS, LP 41,300 $316,358   -41.58% 0.08%
05/15/2024 BARCLAYS PLC 36,909 $282,000   -46.60% 0.07%
05/09/2024 CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 34,832 $266,813   100.00% 0.07%
05/13/2024 BALYASNY ASSET MANAGEMENT L.P. 31,380 $240,371   100.00% 0.06%
05/07/2024 SUSQUEHANNA INTERNATIONAL GROUP, LLP 30,154 $230,980   -30.93% 0.06%

Inozyme Pharma, Inc. institutional Ownership - Frequently Asked Questions

  • Q. Who are the largest shareholders of INZY shares?

    A. During the previous two years, 109 institutional investors and hedge funds held shares of Inozyme Pharma, Inc.. The most heavily invested institutionals were:

    ADAGE CAPITAL PARTNERS GP, L.L.C.: 5.33 M

    Pivotal bioVenture Partners Investment Advisor LLC: 4.49 M

    Sofinnova Investments, Inc.: 4.28 M

    Rock Springs Capital Management LP: 3.68 M

    EVENTIDE ASSET MANAGEMENT, LLC: 3.18 M

    BlackRock Inc.: 3.09 M

  • Q. What percentage of Inozyme Pharma, Inc. stock is owned by institutional investors?

    A. 96.21% of Inozyme Pharma, Inc. stock is owned by institutional investors.

  • Q. How much institutional buying is happening at INZY ?

    A. Institutional investors have bought a total of 57.30 M shares in the last 24 months. This purchase volume represents approximately $257.28 M in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.